Page last updated: 2024-10-29

ifosfamide and Osteosarcoma, Juxtacortical

ifosfamide has been researched along with Osteosarcoma, Juxtacortical in 1 studies

Osteosarcoma, Juxtacortical: A form of osteogenic sarcoma of relatively low malignancy, probably arising from the periosteum and initially involving cortical bone and adjacent connective tissue. It occurs in middle-aged as well as young adults and most commonly affects the lower part of the femoral shaft. (Stedman, 25th ed)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Nodomi, S1
Umeda, K1
Okamoto, T1
Saida, S1
Hiramatsu, H1
Watanabe, K1
Adachi, S1
Heike, T1

Other Studies

1 other study available for ifosfamide and Osteosarcoma, Juxtacortical

ArticleYear
A Pediatric Case of Metastatic Conventional Parosteal Osteosarcoma Treated With Multidrug Chemotherapy.
    Pediatric blood & cancer, 2016, Volume: 63, Issue:8

    Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Cispla

2016